Rules of Submission

1. Each person is permitted to submit and be first author on one abstract. You may co-author as many other abstracts as desired.
2. The first named author must be a delegate for the conference.
3. All authors must approve the abstract.
4. Final abstract acceptance decision is the exclusive right of the AWC25 Free Communications Committee.
5. Human studies must have gained appropriate ethical approval from an institutional review board (IRB) and data must have been collected with participant informed consent in place.
6. Full disclosure of conflict of interests are required, in line with the following policy. In accordance with Qatar Department of Health Practitioners - Accreditation Section and Aspetar CME/CPD Conflict of Interest Policy, all abstract authors must disclose any commercial and/or financial interests over the past 24 months which have a direct or indirect bearing of the design, content orconclusions/recommendations from the presented abstract. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care or related goods or services consumed by, or used on, patients or athletes. Relationships withgovernmental agencies and organizations that do not fit the above definition do not have to be disclosed. Also, you must disclose relevant financial relationships your spouse or life partner has with commercial or financial interests. In accordance with requirements, failure or refusal to provide disclosure information in a timely manner will result in the disqualification of your participation in this activity. This information will only be collated if your abstract is accepted.
7. The first named abstract author must pay any associated registration fee and all other costs associated with travel to the conference, in order for their abstract to be included within the final program. Accepted abstract submissions will receive a 50% discount on conference registration fees.
8. If a speaker needs to apply for a visa for Qatar, they must ensure to obtain it no later than 1^st of October 2025. The Free Communications Committee may require providing confirmation of obtaining the visa before including the paper to the final program.
9. Submissions are only accepted electronically and must be submitted no later than 1 June 23:59 Arabia Standard Time (AST). Late submissions will not be accepted and thus will not be considered. Submissions are to be submitted electronically to this LINK.
10. All submissions must adhere to the stated standardized abstract template and instructions, any submissions which do not, will not be considered.
11. Accepted poster submissions will be available at the conference as e-Posters (no physical printing is necessary), and accepted abstract submitters will be expected to send and/or upload their completed poster before 23:59 (AST) 1 October 2025, in line withprovided instructions. Failure to do so will result in the poster abstract being withdrawn.
12. From the submitted and accepted abstracts, 3 posters and 3 oral presentations will be chosen on merit (final decision is the exclusive right of the Free Communications Committee) during the free communications consideration process. Any prizes (which are not confirmed or guaranteed) will be announced in due course.

Submit your abstract here

Submission guidelines

• Length: The abstract should be a maximum of 500 words (excluding tables and/or figures)
• Title: A brief title
• Authors: First and last full name of all authors, with any middle name limited to a maximum of two initials (e.g. Joe A.B. Bloggs). Academic degrees (e.g. MD, PhD, etc.) and fellowships (e.g. FACSM) are not to be included.
• Institutions: Each author is to include a maximum of three affiliations. Departments are not to be included.
• Text: The abstract must be informative adopting a structured composition, including the following mandatory headings: TITLE, INTRODUCTION, AIM, METHODS, summary of RESULTS, and CONCLUSIONS. It is unsatisfactory to state the results will be discussed. 2 figures and/or tables may be included in the abstract.
• Ethical Institutional Review Board (IRB) Approval Number: This should be included at the end of the abstract.
• Funding Source(s): This should be included at the end of the abstract.
• Abstracts of experimental, observational, and meta-analytic studies must include data to substantiate the conclusions being drawn. Systematic reviews without meta-analyses are not acceptable. It is not satisfactory to simply describe what was found(such as, “the treatment group increased their fitness more than the control group”) or to only include statistical results (such as, “associations were significant at p < .05”) – the inclusion of effect size is strongly encouraged [if adopting a magnitude based inferences (MBI) approach, such reporting must only be conducted on those comparisons that have a significant p value within the adopted statistical model] to support inferentially determined differences and/or relationships. The lack ofinclusion of experimental data may result in the abstract being rejected.
• The abstract must be written in high-quality American English and be grammatically correct. It is strongly recommended that if English is not your first language, you seek proof reading assistance from a colleague with appropriate skills. Unintelligible abstracts will not be given further consideration.